Evergreen Youth Secrets
  • Health News
  • Health Care
  • Staying Healthy
  • Beauty Advices
  • Health News
  • Health Care
  • Staying Healthy
  • Beauty Advices
No Result
View All Result
Evergreen Youth Secrets
No Result
View All Result
Home Health Care

FDA panel picks JN.1 subvariant for fall COVID vaccines

by
June 5, 2024
in Health Care
0
FDA panel picks JN.1 subvariant for fall COVID vaccines

The expert advisory panel for the Food and Drug Administration (FDA) unanimously voted Wednesday in favor of selecting the JN.1 COVID-19 subvariant to be targeted by the next round of COVID-19 vaccines this fall.

The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) was asked if it would recommended a monovalent vaccine that targets the JN.1 omicron subvariant for the 2024-2024 COVID vaccines. All 16 voting members voted in favor of selecting this lineage for the fall.

The JN.1 subvariant is no longer the dominant COVID-19 strain in the U.S., with the most recent surveillance data indicating it makes up less than 10 percent of cases. Current projections estimate that the KP.2 subvariant, from the family of FLiRT subvariants, is the predominant strain in the U.S.

Genomic surveillance data from the Centers for Disease Control and Prevention has not been updated in more than a week, however.

Strain selection for annual vaccines is not necessarily based on what lineage will be most dominant by the time the updates shots are deployed. The aim is to select a strain that is closely related enough to whichever strain is dominant in the country at that time that it provides strong protection.

Though the XBB subvariant lineage was chosen for the vaccines last year, the EG.5 and JN.1 subvariants rose to dominance after the vaccines were made available.

“Our current data suggest that a JN.1 or KP.2 new variant vaccine will protect against JN.1, KP.2, KP.3 and other JN.1 subvariants that are now cocirculating,” a representative for Moderna said in a presentation to VRBPAC.

“From my perspective, I think it’s really hard, just really hard to predict what’s going to happen and where things are going to go,” VRBPAC member Sarah Meyer said following the vote.
“So I do see kind of [a] reason with the thinking that JN.1 is further up on the tree. And so, if we had to guess, we had to choose, that seems to be an appropriate option.”

Previous Post

162 sickened in Salmonella outbreak linked to cucumbers: CDC

Next Post

What to do about mental health crisis among Black males

Next Post
What to do about mental health crisis among Black males

What to do about mental health crisis among Black males

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

    Popular News

    FDA expanding COVID vaccine warnings over rare heart side effect

    FDA expanding COVID vaccine warnings over rare heart side effect

    June 27, 2025
    Supreme Court upholds HHS authority over ObamaCare preventative care task force

    Supreme Court upholds HHS authority over ObamaCare preventative care task force

    June 27, 2025
    Unusual pushback, ‘dangerous precedent’: What the first meeting of Kennedy’s CDC advisers reveals about the future of vaccines in America

    Unusual pushback, ‘dangerous precedent’: What the first meeting of Kennedy’s CDC advisers reveals about the future of vaccines in America

    June 27, 2025

    Trending

    Trump predicts drug prices will ‘drop like a rock’ after new executive order

    Trump predicts drug prices will ‘drop like a rock’ after new executive order

    May 22, 2025
    Novo Nordisk partners with Ro, Hims and LifeMD to sell low-cost Wegovy

    Novo Nordisk partners with Ro, Hims and LifeMD to sell low-cost Wegovy

    April 29, 2025
    NH resident dies after testing positive for mosquito-borne virus

    NH resident dies after testing positive for mosquito-borne virus

    August 27, 2024
    Gender gap on abortion rights hit record high: Gallup

    Gender gap on abortion rights hit record high: Gallup

    June 9, 2025

    Recent News

    FDA expanding COVID vaccine warnings over rare heart side effect

    FDA expanding COVID vaccine warnings over rare heart side effect

    June 27, 2025
    Supreme Court upholds HHS authority over ObamaCare preventative care task force

    Supreme Court upholds HHS authority over ObamaCare preventative care task force

    June 27, 2025

    Popular News

    • FDA expanding COVID vaccine warnings over rare heart side effect
    • Supreme Court upholds HHS authority over ObamaCare preventative care task force

    About Evergreen Youth Secrets

    • Contact us
    • Privacy Policy
    • Terms & Conditions
    • Email Whitelisting

    Copyright © 2025 Evergreenyouthsecrets.com. All Rights Reserved.

    No Result
    View All Result
    • Health News
    • Health Care
    • Staying Healthy
    • Beauty Advices

    Copyright © 2025 Evergreenyouthsecrets.com. All Rights Reserved.